4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-005117
EVP, Research & CSO sold 1,375 shares at $32.46 ($44,633)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2022-01-25 | Option exercise | +1,375 | $1.53 | $2,104 | 109,075 | D |
| Virgin Herbert EVP, Research & CSO | 2022-01-25 | Sale | −1,375 | $32.46 | $44,633 | 107,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2022-01-25 | Option exercise · Stock Option (Right to Buy) | −1,375 | 222,255 | D | ||
| Open-market sales · 1,375 sh · avg $32.46 · $44,633 | |||||||
Loading xslF345X03/doc4.xml…